Literature DB >> 20009824

Gracilis myocutaneous free flap in autologous breast reconstruction.

Stephen J Vega1, Sven N Sandeen, Ronald P Bossert, Anthony Perrone, Luis Ortiz, Hector Herrera.   

Abstract

BACKGROUND: The gracilis myocutaneous free flap provides an alternative for autologous breast reconstruction. It avoids abdominal donor-site morbidity, allows for a quicker recovery, provides an alternative to the thin patient with a hidden and acceptable donor site, and allows for supine positioning for harvest and inset in a timely fashion.
METHODS: A retrospective review was conducted of all autogenous postmastectomy reconstructions performed between January of 2005 and March of 2008. All patients receiving gracilis myocutaneous flap reconstruction for postmastectomy defects were included in this study. Office and hospital charts were reviewed.
RESULTS: Twenty-seven gracilis flaps were performed during the study period. Average patient age was 50.4 years (range, 35 to 63.4 years), and average body mass index was 25.6 (range, 19.4 to 35.5). Of the 21 patients, 9.5 percent had hypertension, 19 percent smoked, none were diabetic, 14 percent were obese, and 4.8 percent had documented cardiovascular disease. Outcomes included a flap success rate of 100 percent, average operating time of 4.9 hours for unilateral (15 patients) and 6.7 hours for bilateral (six patients) flaps, intraoperative arterial thrombosis rate of 13.6 percent, average hospital stay of 3.75 days, major complication rate of 7.4 percent, and average follow-up of 7 months.
CONCLUSIONS: The gracilis myocutaneous free flap provides an alternative breast reconstruction option for today's breast cancer patient. It allows for a quick harvest in the supine setting, creation of a moderate breast volume, consistent anatomy, and acceptable donor-site morbidity with good contour.

Entities:  

Mesh:

Year:  2009        PMID: 20009824     DOI: 10.1097/PRS.0b013e3181babb19

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  8 in total

Review 1.  Achieving ideal breast aesthetics with autologous reconstruction.

Authors:  Maurice Y Nahabedian
Journal:  Gland Surg       Date:  2015-04

2.  The transverse upper gracilis flap: Efficiencies and design tips.

Authors:  Edward W Buchel; Kimberly R Dalke; Thomas Ej Hayakawa
Journal:  Can J Plast Surg       Date:  2013

3.  The gracilis myocutaneous free flap: a quantitative analysis of the fasciocutaneous blood supply and implications for autologous breast reconstruction.

Authors:  Iain S Whitaker; Maria Karavias; Ramin Shayan; Cara Michelle le Roux; Warren M Rozen; Russell J Corlett; G Ian Taylor; Mark W Ashton
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

4.  The transversely split gracilis twin free flaps.

Authors:  Divya N Upadhyaya; Vaibhav Khanna; Surajit Bhattacharya; Sandeep Garg; Romesh Kohli
Journal:  Indian J Plast Surg       Date:  2010-07

5.  Bilateral Simultaneous Breast Reconstruction with DIEP- and TMG Flaps: Head to Head Comparison, Risk and Complication Analysis.

Authors:  Laurenz Weitgasser; Karl Schwaiger; Fabian Medved; Felix Hamler; Gottfried Wechselberger; Thomas Schoeller
Journal:  J Clin Med       Date:  2020-06-28       Impact factor: 4.241

6.  The Conjoined TUGPAP Flap for Breast Reconstruction: Systematic Review and Illustrative Anatomy.

Authors:  Aneesh Karir; Michael J Stein; Jing Zhang
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-04-20

7.  Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap.

Authors:  Angela Augustin; Petra Pülzl; Evi M Morandi; Selina Winkelmann; Ines Schoberleitner; Christine Brunner; Magdalena Ritter; Thomas Bauer; Tanja Wachter; Dolores Wolfram
Journal:  Curr Oncol       Date:  2022-08-11       Impact factor: 3.109

8.  Age and Overweight Are Not Contraindications for a Breast Reconstruction with a TMG-Flap-A Risk and Complication Analysis of a Retrospective Double Center Study Including 300 Patients.

Authors:  Karl Schwaiger; Laurenz Weitgasser; Maximilian Mahrhofer; Kathrin Bachleitner; Selim Abed; Julia Wimbauer; Elisabeth Russe; Thomas Schoeller; Gottfried Wechselberger
Journal:  J Clin Med       Date:  2021-03-01       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.